Skip to main content

Table 2 Clinical information of patients with LUSC from the GEO database

From: Survival-associated N6-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification

Clinical information

Number

Percentage

Total cases

181

100

Survival status

 Alive

74

40.88

 Dead

107

59.12

Over survival time

  < 1 year

38

20.99

 1–5 years

97

53.59

  > 5 years

46

25.42

Age

  < 65

78

43.09

  ≥ 65

103

56.91

Gender

 Male

138

76.24

 Female

43

23.76